Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, ...

BTIG lowered the firm’s price target on Outset Medical (OM) to $3 from $4 and keeps a Buy rating on the shares. The firm is updating its model ...

Inc. (NASDAQ:OM), reported several stock transactions, according to a recent SEC filing. The company's stock, currently trading at $0.78, has experienced significant volatility, falling nearly 80% ...

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

Ahmed Nabeel, the Chief Financial Officer of Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), recently reported a series of stock transactions in a filing with the Securities and Exchange Commission.

Outset Medical's financial trajectory has shown signs of improvement, despite facing challenges. In its Q3 2024 earnings report, the company surpassed expectations and subsequently raised its 2024 ...

Outset Medical is set to present at the prestigious 43rd annual J.P. Morgan Healthcare conference, which could enhance visibility and credibility within the healthcare sector. The company's ...

Outset Medical, Inc. SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...

Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This ...

SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...

SAN JOSE, CA – Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), a medical technology company with a market capitalization of $52 million, announced the closure of a private placement offering and the ...